trending Market Intelligence /marketintelligence/en/news-insights/trending/h0awwvKBunZrOVXdy41hlg2 content esgSubNav
In This List

US FDA approves CYBERDYNE's lower limb medical device

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


US FDA approves CYBERDYNE's lower limb medical device

The U.S. Food and Drug Administration approved CYBERDYNE Inc.'s hybrid assistive limb medical device.

The Hybrid assistive limb device is meant for people who have lower limb disorders or those whose legs are weakening.